Company news
Biocon Limited news in 2026
Biocon Limited's news releases, calls and decks from 2026, newest first.
Biocon Limited has informed the Exchange regarding a press release dated November 04, 2026, titled "Press Release on financial results for the quarter and half-year ended September 30, 2026".
November 4, 2026
Biocon Limited has informed the Exchange regarding a press release dated October 29, 2026, titled "Biocon Named Among Science Magazine s Best Employers in Global Biotech and Pharma for 2026".
October 28, 2026
Biocon's Pertuzumab Becomes First Biosimilar to Secure EMA CHMP Approval Recommendation Under New Tailored Clinical Approach
September 22, 2026
Biocon Limited Press Release Sep 21 2026
September 20, 2026
Biocon Limited Press Release Sep 08 2026
September 7, 2026
Biocon Announces Supplemental U.S. FDA Approval For Prefilled Autoinjector For YESINTEK
September 2, 2026
Biocon Launches Aflibercept Biosimilar In The United States
August 24, 2026
Biocon Limited Press Release Aug 05 2026
August 5, 2026
Biocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron’s Eylea® 2 mg
August 3, 2026
Biocon Limited Press Release Aug 03 2026
August 2, 2026
Biocon Announces Publication of Pivotal Clinical Data Supporting Effectiveness of Yesafili, a Biosimilar to Eylea
July 10, 2026
Biocon Announces Publication of Pivotal Clinical Data Supporting Effectiveness of Yesafili™, a Biosimilar to Eylea® (Aflibercept)
July 9, 2026
Biocon Limited Press Release Jul 09 2026
July 8, 2026
Biocon Limited Press Release Jun 24 2026
June 23, 2026
Press Release May 07 2026
May 7, 2026
Press Release Apr 21 2026
April 21, 2026
Biocon Receives Health Canada Approval of Bosaya™ (Denosumab) and Vevzuo™ (Denosumab), Biosimilars to Prolia® and Xgeva®
April 21, 2026
Biocon Limited Press Release Apr 21 2026
April 20, 2026
Press Release Apr 07 2026
April 7, 2026
Shreehas Tambe Appointed CEO and Managing Director of Biocon Limited, Effective April 1, 2026
March 30, 2026
Press Release Mar 27 2026
March 27, 2026
Press Release Feb 24 2026
February 24, 2026
Press Release Feb 12 2026
February 12, 2026
Press Release Feb 07 2026
February 7, 2026
Press Release Jan 28 2026
January 28, 2026
Biocon Limited Press Release Jan 28 2026
January 27, 2026
Press Release Jan 15 2026
January 15, 2026
Biocon Limited Press Release Jan 15 2026
January 14, 2026
Press Release Jan 06 2026
January 6, 2026
Biocon Biologics to Expand Biosimilar Oncology Portfolio, Outline Strategic Vision at the 2026 J.P. Morgan Healthcare Conference
January 6, 2026
Decks in 2026
- Q2 FY27 Earnings Presentation
Earnings · 18 slides · Nov 4, 2026
- Q1 FY27 Earnings Presentation
Earnings · 16 slides · Aug 6, 2026
- Investor Presentation (June 2026)
Investor deck · 31 slides · June 2026
- Q4 FY26 Earnings Presentation
Earnings · 17 slides · May 8, 2026
- Investor Presentation (February 2026)
Investor deck · 34 slides · Feb 25, 2026
- Q3 FY26 Earnings Presentation
Earnings · 16 slides · Feb 13, 2026
- Investor Presentation (February 2026)
Investor deck · 33 slides · February 2026
- 44th Annual J.P. Morgan Healthcare Conference (January 2026)
Conference · 20 slides · Jan 15, 2026